A biopharmaceutical company that develops novel drugs for pain management and oncology.


Updates from The Motley Fool

Latest updates on Pain Therapeutics from Fool.com.
This Week in Biotech

An FDA approval, exciting early-stage pancreatic cancer data, the revival of a drug that will not...

This Week in Biotech

An FDA approval provides a boost to two companies, while two separate clinical updates send share...

This Week in Biotech

FDA rulings, comments, and earnings reports take center stage this week.

3 Top Stocks at Half-Price

Investors still think highly of these companies, despite their fire-sale prices.



Stock Performance

View Interactive PTIE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Pain Therapeutics.
Current Price: $1.09
Prev Close: $1.10
Open: $1.10
Bid: $1.09
Ask: $1.10
Day's Range: $1.06 - $1.12
52wk Range: $0.76 - $10.87
Volume: 178,996
Avg Vol 342,993
Market Cap: $19M
P/E (ttm): -1.04
EPS (ttm): -$1.06
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Pain Therapeutics.
CAPS Rating 1 out of 5
 
171 Outperform
37 Underperform
CAPS All Stars
 
28 Outperform
19 Underperform

How do you think Pain Therapeutics will perform against the market?



You pick for Pain Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Remi Barbier, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Pain Therapeutics.

A biopharmaceutical company that develops novel drugs for pain management and oncology.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers